Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804.
McCormick B, Winter KA, Woodward W, Kuerer HM, Sneige N, Rakovitch E, Smith BL, Germain I, Hartford AC, O'Rourke MA, Walker EM, Strom EA, Hopkins JO, Pierce LJ, Pu AT, Sumida KNM, Vesprini D, Moughan J, White JR. McCormick B, et al. J Clin Oncol. 2021 Nov 10;39(32):3574-3582. doi: 10.1200/JCO.21.01083. Epub 2021 Aug 18. J Clin Oncol. 2021. PMID: 34406870 Free PMC article. Clinical Trial.
Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma.
Shimodaira Y, Slack RS, Harada K, Bhutani MS, Elimova E, Staerkel GA, Sneige N, Erasmus J, Shiozaki H, Charalampakis N, Planjery V, Kaya DM, Amlashi FG, Blum MA, Skinner HD, Minsky BD, Maru DM, Hofstetter WL, Swisher SG, Mares JE, Rogers JE, Lin QD, Ross WA, Weston B, Lee JH, Ajani JA. Shimodaira Y, et al. Oncotarget. 2017 May 23;8(45):79356-79365. doi: 10.18632/oncotarget.18119. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108314 Free PMC article.
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.
Arun BK, Gong Y, Liu D, Litton JK, Gutierrez-Barrera AM, Jack Lee J, Vornik L, Ibrahim NK, Cornelison T, Hortobagyi GN, Heckman-Stoddard BM, Koenig KB, Alvarez RR, Murray JL, Valero V, Lippman SM, Brown P, Sneige N. Arun BK, et al. Breast Cancer Res Treat. 2016 Jul;158(1):67-77. doi: 10.1007/s10549-016-3849-1. Epub 2016 Jun 10. Breast Cancer Res Treat. 2016. PMID: 27287781 Free PMC article. Clinical Trial.
RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.
McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, Sneige N, Moughan J, Shah A, Germain I, Hartford AC, Rashtian A, Walker EM, Yuen A, Strom EA, Wilcox JL, Vallow LA, Small W Jr, Pu AT, Kerlin K, White J. McCormick B, et al. J Clin Oncol. 2015 Mar 1;33(7):709-15. doi: 10.1200/JCO.2014.57.9029. Epub 2015 Jan 20. J Clin Oncol. 2015. PMID: 25605856 Free PMC article. Clinical Trial.
Web based pathology assessment in RTOG 98-04.
Woodward WA, Sneige N, Winter K, Kuerer HM, Hudis C, Rakovitch E, Smith BL, Pierce LJ, Germano I, Pu AT, Walker EM, Grisell DL, White JR, McCormick B; Radiation Therapy Oncology Group (RTOG). Woodward WA, et al. J Clin Pathol. 2014 Sep;67(9):777-80. doi: 10.1136/jclinpath-2014-202370. J Clin Pathol. 2014. PMID: 24989024 Free PMC article.
Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer.
Crew KD, Ho KA, Brown P, Greenlee H, Bevers TB, Arun B, Sneige N, Hudis C, McArthur HL, Chang J, Rimawi M, Cornelison TL, Cardelli J, Santella RM, Wang A, Lippman SM, Hershman DL. Crew KD, et al. J Hum Nutr Diet. 2015 Jun;28(3):272-82. doi: 10.1111/jhn.12229. Epub 2014 Mar 19. J Hum Nutr Diet. 2015. PMID: 24646362 Free PMC article. Clinical Trial.
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.
Pogue-Geile KL, Kim C, Jeong JH, Tanaka N, Bandos H, Gavin PG, Fumagalli D, Goldstein LC, Sneige N, Burandt E, Taniyama Y, Bohn OL, Lee A, Kim SI, Reilly ML, Remillard MY, Blackmon NL, Kim SR, Horne ZD, Rastogi P, Fehrenbacher L, Romond EH, Swain SM, Mamounas EP, Wickerham DL, Geyer CE Jr, Costantino JP, Wolmark N, Paik S. Pogue-Geile KL, et al. J Natl Cancer Inst. 2013 Dec 4;105(23):1782-8. doi: 10.1093/jnci/djt321. Epub 2013 Nov 21. J Natl Cancer Inst. 2013. PMID: 24262440 Free PMC article. Clinical Trial.
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis.
Geyer FC, Lacroix-Triki M, Colombo PE, Patani N, Gauthier A, Natrajan R, Lambros MB, Khalifeh I, Albarracin C, Orru S, Marchiò C, Sapino A, Mackay A, Weigelt B, Schmitt FC, Wesseling J, Sneige N, Reis-Filho JS. Geyer FC, et al. Histopathology. 2012 May;60(6B):E115-30. doi: 10.1111/j.1365-2559.2012.04207.x. Epub 2012 Apr 4. Histopathology. 2012. PMID: 22486256 Free article.
Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results.
Arun BK, Dhinghra K, Valero V, Kau SW, Broglio K, Booser D, Guerra L, Yin G, Walters R, Sahin A, Ibrahim N, Buzdar AU, Frye D, Sneige N, Strom E, Ross M, Theriault RL, Vadhan-Raj S, Hortobagyi GN. Arun BK, et al. Oncologist. 2011;16(11):1527-34. doi: 10.1634/theoncologist.2011-0134. Epub 2011 Oct 31. Oncologist. 2011. PMID: 22042783 Free PMC article. Clinical Trial.
Is it too soon to start reporting HER2 genetic heterogeneity?
Albarracin C, Edgerton ME, Gilcrease MZ, Huo L, Krishnamurthy S, Middleton LP, Resetkova E, Sahin AA, Sneige N, Fraser WS, Wu Y. Albarracin C, et al. Arch Pathol Lab Med. 2010 Feb;134(2):162-3; author reply 163. doi: 10.5858/134.2.162.b. Arch Pathol Lab Med. 2010. PMID: 20121597 Free article. No abstract available.
Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.
Gong Y, Sweet W, Duh YJ, Greenfield L, Tarco E, Trivedi S, Symmans WF, Isola J, Sneige N. Gong Y, et al. Am J Clin Pathol. 2009 Aug;132(2):228-36. doi: 10.1309/AJCP4M2VUZCLDALN. Am J Clin Pathol. 2009. PMID: 19605817
Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases.
Middleton LP, Price KM, Puig P, Heydon LJ, Tarco E, Sneige N, Barr K, Deavers MT. Middleton LP, et al. Arch Pathol Lab Med. 2009 May;133(5):775-80. doi: 10.5858/133.5.775. Arch Pathol Lab Med. 2009. PMID: 19415952 Free article.
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
Hess KR, Anderson K, Symmans WF, Valero V, Ibrahim N, Mejia JA, Booser D, Theriault RL, Buzdar AU, Dempsey PJ, Rouzier R, Sneige N, Ross JS, Vidaurre T, Gómez HL, Hortobagyi GN, Pusztai L. Hess KR, et al. J Clin Oncol. 2006 Sep 10;24(26):4236-44. doi: 10.1200/JCO.2006.05.6861. Epub 2006 Aug 8. J Clin Oncol. 2006. PMID: 16896004
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM. Adepoju LJ, et al. Cancer. 2006 Jan 1;106(1):42-50. doi: 10.1002/cncr.21571. Cancer. 2006. PMID: 16333852 Free article.
A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding.
Symmans WF, Fiterman DJ, Anderson SK, Ayers M, Rouzier R, Dunmire V, Stec J, Valero V, Sneige N, Albarracin C, Wu Y, Ross JS, Wagner P, Theriault RL, Arun B, Kuerer H, Hess KR, Zhang W, Hortobagyi GN, Pusztai L. Symmans WF, et al. Endocr Relat Cancer. 2005 Dec;12(4):1059-69. doi: 10.1677/erc.1.01051. Endocr Relat Cancer. 2005. PMID: 16322343
p53 expression as a prognostic marker in inflammatory breast cancer.
Gonzalez-Angulo AM, Sneige N, Buzdar AU, Valero V, Kau SW, Broglio K, Yamamura Y, Hortobagyi GN, Cristofanilli M. Gonzalez-Angulo AM, et al. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6215-21. doi: 10.1158/1078-0432.CCR-04-0202. Clin Cancer Res. 2004. PMID: 15448010
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer.
Ayers M, Symmans WF, Stec J, Damokosh AI, Clark E, Hess K, Lecocke M, Metivier J, Booser D, Ibrahim N, Valero V, Royce M, Arun B, Whitman G, Ross J, Sneige N, Hortobagyi GN, Pusztai L. Ayers M, et al. J Clin Oncol. 2004 Jun 15;22(12):2284-93. doi: 10.1200/JCO.2004.05.166. Epub 2004 May 10. J Clin Oncol. 2004. PMID: 15136595
Breast carcinoma with choriocarcinomatous features.
Resetkova E, Sahin A, Ayala AG, Sneige N. Resetkova E, et al. Ann Diagn Pathol. 2004 Apr;8(2):74-9. doi: 10.1053/j.anndiagpath.2004.01.003. Ann Diagn Pathol. 2004. PMID: 15060884
Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.
Woodward WA, Strom EA, Tucker SL, Katz A, McNeese MD, Perkins GH, Buzdar AU, Hortobagyi GN, Hunt KK, Sahin A, Meric F, Sneige N, Buchholz TA. Woodward WA, et al. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):336-44. doi: 10.1016/s0360-3016(03)00593-5. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957243
Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.
Pusztai L, Ayers M, Stec J, Clark E, Hess K, Stivers D, Damokosh A, Sneige N, Buchholz TA, Esteva FJ, Arun B, Cristofanilli M, Booser D, Rosales M, Valero V, Adams C, Hortobagyi GN, Symmans WF. Pusztai L, et al. Clin Cancer Res. 2003 Jul;9(7):2406-15. Clin Cancer Res. 2003. PMID: 12855612
Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma.
Symmans WF, Ayers M, Clark EA, Stec J, Hess KR, Sneige N, Buchholz TA, Krishnamurthy S, Ibrahim NK, Buzdar AU, Theriault RL, Rosales MF, Thomas ES, Gwyn KM, Green MC, Syed AR, Hortobagyi GN, Pusztai L. Symmans WF, et al. Cancer. 2003 Jun 15;97(12):2960-71. doi: 10.1002/cncr.11435. Cancer. 2003. PMID: 12784330 Free article.
Nipple aspirate fluid cytology in breast carcinoma.
Krishnamurthy S, Sneige N, Thompson PA, Marcy SM, Singletary SE, Cristofanilli M, Hunt KK, Kuerer HM. Krishnamurthy S, et al. Cancer. 2003 Apr 25;99(2):97-104. doi: 10.1002/cncr.10958. Cancer. 2003. PMID: 12704689 Free article.
Histologic localization of sentinel lymph node metastases in breast cancer.
Diaz LK, Hunt K, Ames F, Meric F, Kuerer H, Babiera G, Ross M, Singletary E, Middleton LP, Symmans WF, Krishnamurthy S, Sahin A, Sneige N, Gilcrease MZ. Diaz LK, et al. Am J Surg Pathol. 2003 Mar;27(3):385-9. doi: 10.1097/00000478-200303000-00012. Am J Surg Pathol. 2003. PMID: 12604895
Characterization of foam cells in nipple aspirate fluid.
Krishnamurthy S, Sneige N, Ordóñez NG, Hunt KK, Kuerer HM. Krishnamurthy S, et al. Diagn Cytopathol. 2002 Nov;27(5):261-4; discussion 265. doi: 10.1002/dc.10155. Diagn Cytopathol. 2002. PMID: 12411988
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, Tucker SL. Buchholz TA, et al. Int J Radiat Oncol Biol Phys. 2002 Jul 15;53(4):880-8. doi: 10.1016/s0360-3016(02)02850-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12095553
Interventional breast sonography.
Fornage BD, Sneige N, Edeiken BS. Fornage BD, et al. Eur J Radiol. 2002 Apr;42(1):17-31. doi: 10.1016/s0720-048x(01)00481-8. Eur J Radiol. 2002. PMID: 12039017 Review.
Radiofrequency ablation of early-stage invasive breast tumors: an overview.
Singletary SE, Fornage BD, Sneige N, Ross MI, Simmons R, Giuliano A, Hansen N, Kuerer HM, Newman LA, Ames FC, Babiera G, Meric F, Hunt KK, Edeiken B, Mirza AN. Singletary SE, et al. Cancer J. 2002 Mar-Apr;8(2):177-80. doi: 10.1097/00130404-200203000-00011. Cancer J. 2002. PMID: 11999950 Review.
Paclitaxel in the multimodality treatment for inflammatory breast carcinoma.
Cristofanilli M, Buzdar AU, Sneige N, Smith T, Wasaff B, Ibrahim N, Booser D, Rivera E, Murray JL, Valero V, Ueno N, Singletary ES, Hunt K, Strom E, McNeese M, Stelling C, Hortobagyi GN. Cristofanilli M, et al. Cancer. 2001 Oct 1;92(7):1775-82. doi: 10.1002/1097-0142(20011001)92:7<1775::aid-cncr1693>3.0.co;2-e. Cancer. 2001. PMID: 11745249 Clinical Trial.
Radiation Therapy Oncology Group. Research Plan 2002-2006. Pathology Committee.
Grignon D, Amin M, Brat D, El-Nagaar A, Hammond E, Lucas D, Nelson J, Petito C, Scott C, Sheahan DG, Sneige N, True L, Yesner R; Radiation Therapy Oncology Group. Grignon D, et al. Int J Radiat Oncol Biol Phys. 2001;51(3 Suppl 2):110-2. Int J Radiat Oncol Biol Phys. 2001. PMID: 11641025 No abstract available.
Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research Program.
Okunieff P, Hammond E, Grignon D, Langer C, Pajak TF, Ang K, Bruner DW, Travis E, Greven K, Guha A, Moulder J, Pollack A, Scarantino C, Sneige N, Watson J, Amin M, Bondy M, Chakravarti A, Chapman JD, Dicker A, Harris J, Koch W, Komaki R, Lange C, McBride W, Mitchell J, Milas L, Movsas B, Pandya K, Pienta K, Regine W, Ritter M, Rubin P, Safran H, Sauter E, Schell M, Stevens C, Trotti A, Vikram B; Radiation Therapy Oncology Group. Okunieff P, et al. Int J Radiat Oncol Biol Phys. 2001;51(3 Suppl 2):75-87. Int J Radiat Oncol Biol Phys. 2001. PMID: 11641020 No abstract available.
Radiation Therapy Oncology Group. Research Plan 2002-2006. Breast Cancer Working Group.
McCormick B, Strom E, Craighead PS, Kuske R, Hudis C, Ley J, Margolis L, Meyerwitz B, Morris E, Petrek J, Pierce L, Pisansky T, Rabinovitch R, Sneige N, Vicini F, Unger D, Winter K; Radiation Therapy Oncology Group. McCormick B, et al. Int J Radiat Oncol Biol Phys. 2001;51(3 Suppl 2):56-7. Int J Radiat Oncol Biol Phys. 2001. PMID: 11641016 No abstract available.
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial.
Hortobagyi GN, Ueno NT, Xia W, Zhang S, Wolf JK, Putnam JB, Weiden PL, Willey JS, Carey M, Branham DL, Payne JY, Tucker SD, Bartholomeusz C, Kilbourn RG, De Jager RL, Sneige N, Katz RL, Anklesaria P, Ibrahim NK, Murray JL, Theriault RL, Valero V, Gershenson DM, Bevers MW, Huang L, Lopez-Berestein G, Hung MC. Hortobagyi GN, et al. J Clin Oncol. 2001 Jul 15;19(14):3422-33. doi: 10.1200/JCO.2001.19.14.3422. J Clin Oncol. 2001. PMID: 11454891 Clinical Trial.
Radiofrequency ablation of solid tumors.
Mirza AN, Fornage BD, Sneige N, Kuerer HM, Newman LA, Ames FC, Singletary SE. Mirza AN, et al. Cancer J. 2001 Mar-Apr;7(2):95-102. Cancer J. 2001. PMID: 11324771 Review.
Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide.
Singletary E, Lieberman R, Atkinson N, Sneige N, Sahin A, Tolley S, Colchin M, Bevers T, Stelling C, Fornage B, Fritsche H, Hittelman W, Kelloff G, Lippman SM. Singletary E, et al. Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1087-90. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11045792 Clinical Trial.
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
Hortobagyi GN, Buzdar AU, Theriault RL, Valero V, Frye D, Booser DJ, Holmes FA, Giralt S, Khouri I, Andersson B, Gajewski JL, Rondon G, Smith TL, Singletary SE, Ames FC, Sneige N, Strom EA, McNeese MD, Deisseroth AB, Champlin RE. Hortobagyi GN, et al. J Natl Cancer Inst. 2000 Feb 2;92(3):225-33. doi: 10.1093/jnci/92.3.225. J Natl Cancer Inst. 2000. PMID: 10655439 Clinical Trial.
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.
Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N, Buchholz TA, Ross MI, McNeese MD, Buzdar AU, Hortobagyi GN, Singletary SE. Kuerer HM, et al. J Clin Oncol. 1999 Feb;17(2):460-9. doi: 10.1200/JCO.1999.17.2.460. J Clin Oncol. 1999. PMID: 10080586 Clinical Trial.
Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 investigators.
Pisano ED, Fajardo LL, Tsimikas J, Sneige N, Frable WJ, Gatsonis CA, Evans WP, Tocino I, McNeil BJ. Pisano ED, et al. Cancer. 1998 Feb 15;82(4):679-88. doi: 10.1002/(sici)1097-0142(19980215)82:4<679::aid-cncr10>3.0.co;2-v. Cancer. 1998. PMID: 9477100 Clinical Trial.
Abnormal expression of MDM-2 in breast carcinomas.
Bueso-Ramos CE, Manshouri T, Haidar MA, Yang Y, McCown P, Ordonez N, Glassman A, Sneige N, Albitar M. Bueso-Ramos CE, et al. Breast Cancer Res Treat. 1996;37(2):179-88. doi: 10.1007/BF01806499. Breast Cancer Res Treat. 1996. PMID: 8750585
274 results